Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H25N5O2 |
InChIKeyHGUCVADITYSNHR-IBGZPJMESA-N |
CAS Registry2851977-85-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Sep 2022 |